Merkow v. Allergan USA, Inc. et al
| Bari Merkow |
| Allergan USA, Inc., Allergan plc, AbbVie Inc. and Allergan, Inc. f/k/a Inamed Corporation |
| 1:2022cv07266 |
| August 25, 2022 |
| US District Court for the Southern District of New York |
| Ronnie Abrams |
| Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
| 28 U.S.C. ยง 1332 Diversity Action |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on September 13, 2022. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Received e-mail from the United States District Court - District of New Jersey acknowledging receipt of transferred case. Assigned Case Number: 2:22-cv-05517, filed on 9/13/2022. (vba) |
| MDL TRANSFER OUT ELECTRONICALLY: to the United States District Court - Newark District of New Jersey.(vba) |
| Filing 6 CERTIFIED TRUE COPY OF CONDITIONAL MDL TRANSFER OUT ORDER FROM THE MDL PANEL...transferring this action from the U.S.D.C. - S.D.N.Y to the United States District Court - Newark District of New Jersey. (Signed by MDL Panel on 9/9/2022) (vba) |
Filing 5
JOINT STIPULATION TO EXTEND TIME TO FILE A RESPONSIVE PLEADING: Plaintiff Bari Merkow, and Defendants Allergan USA, Inc., Allergan, Inc. f/k/a Inamed Corporation, Allergan PLC and Abbvie Inc. 1(collectively, "Allergan") by and through undersigned counsel, jointly stipulate to and request this Court extend Allergan's responsive pleading deadline until fourteen days after the Judicial Panel on Multidistrict Litigation (JPML) determines whether this case should be transferred to MDL 2921, In re Allergan Biocell Textured Breast Implant Products Liability Litigation. In support thereof, the Parties state as follows: as set forth herein. Application Granted. SO ORDERED. (Signed by Judge Ronnie Abrams on 9/02/2022) (ama)
|
| Filing 4 PROPOSED STIPULATION AND ORDER. Document filed by AbbVie Inc., Allergan USA, Inc., Allergan, Inc. f/k/a Inamed Corporation..(Russo, Shana) |
| ***NOTICE TO ATTORNEY REGARDING DEFICIENT RULE 7.1 CORPORATE DISCLOSURE STATEMENT. Notice to Attorney Shana Eve Russo to RE-FILE Document No. #3 Rule 7.1 Corporate Disclosure Statement,. The filing is deficient for the following reason(s): not all corporate parents/other affiliates were added;. Re-file the document using the event type Rule 7.1 Corporate Disclosure Statement found under the event list Other Documents - select the correct filer/filers - attach the correct PDF - when prompted with the message "Are there any corporate parents or other affiliates?", select the Yes radio button - enter the corporate parent/other affiliate, click the Search button - select the correct corporate parent/other affiliate name from the search results list or if no person found, create a new corporate parent/other affiliate - select the party to whom the corporate parent/other affiliate should be linked - add corporate parent/other affiliate names one at a time. (lb) |
| Case Designated ECF. (pc) |
| Magistrate Judge Robert W. Lehrburger is so designated. Pursuant to 28 U.S.C. Section 636(c) and Fed. R. Civ. P. 73(b)(1) parties are notified that they may consent to proceed before a United States Magistrate Judge. Parties who wish to consent may access the necessary form at the following link: #https://nysd.uscourts.gov/sites/default/files/2018-06/AO-3.pdf. (pc) |
| CASE OPENING INITIAL ASSIGNMENT NOTICE: The above-entitled action is assigned to Judge Ronnie Abrams. Please download and review the Individual Practices of the assigned District Judge, located at #https://nysd.uscourts.gov/judges/district-judges. Attorneys are responsible for providing courtesy copies to judges where their Individual Practices require such. Please download and review the ECF Rules and Instructions, located at #https://nysd.uscourts.gov/rules/ecf-related-instructions..(pc) |
| Filing 3 FILING ERROR - NOT ALL CORPORATE PARENTS/OTHER AFFILIATES WERE ADDED - RULE 7.1 CORPORATE DISCLOSURE STATEMENT. Identifying Corporate Parent AbbVie Inc. for AbbVie Inc., Allergan USA, Inc., Allergan plc, Allergan, Inc. f/k/a Inamed Corporation. Document filed by AbbVie Inc., Allergan USA, Inc., Allergan plc, Allergan, Inc. f/k/a Inamed Corporation..(Russo, Shana) Modified on 8/25/2022 (lb). |
| Filing 2 CIVIL COVER SHEET filed..(Russo, Shana) |
| Filing 1 NOTICE OF REMOVAL from Supreme Court, County of New York. Case Number: 152404/2022. (Filing Fee $ 402.00, Receipt Number ANYSDC-26595029).Document filed by AbbVie Inc., Allergan plc, Allergan USA, Inc., Allergan, Inc. f/k/a Inamed Corporation. (Attachments: #1 Exhibit A to Notice of Removal, #2 Exhibit B to Notice of Removal).(Russo, Shana) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New York Southern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
